Here’s what you should know:
1. BidaskClub assigned Surgery Partners a sell rating in its latest research note.
2. Stifel Nicolaus assigned the company a hold rating, but dropped its price objective from $19 a share to $18 a share.
3. On average analysts project a price target of $21.40 for Surgery Partners.
4. Surgery Partners closed Jan. 24 at $21.38.
More articles on transactions/valuations:
Concord Orthopaedics’ ASC plans up in the air due to rezoning concerns: 4 takeaways
Compass Surgical Partners opens multispecialty ASC & more — 5 ASC company key notes
Compass Surgical Partners opens freestanding Florida ASC: 4 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
